Alphatec Holdings Inc (ATEC)

NASD · Healthcare · Medical Devices · USA

Alphatec Holdings Inc is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.

Alphatec Holdings Inc is a medical technology company that designs and develops technology for surgical treatment of spine disorders. The company offers a comprehensive product portfolio addressing various spine pathologies, including the Prone TransPsoas approach, implants, and EOS imaging software. Its customers are spine surgeons, hospitals, and healthcare systems.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Alphatec Holdings Inc stock.

Our verdict on ATEC

Slightly overvalued: intrinsic value $6.25 per share, market price $6.94, margin of safety -11.0% (as of 2026-11-17).

A 1.6x revenue multiple, discounted for its losses, values the shares at $6.25; the price of $6.94 is 11% above that value.

ETFs with the most weight in ATEC

17 more funds hold it; the full list is part of the paid plan.

More on ATEC

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than ATEC in Medical Devices

16 more in this industry show a wider margin of safety.

Is ATEC undervalued or overvalued?

ATEC is slightly overvalued (as of the 2026-11-17 close). A 1.6x revenue multiple, discounted for its losses, values the shares at $6.25; the price of $6.94 is 11% above that value.

What is the intrinsic value of ATEC?

$6.25 per share (as of the 2026-11-17 close), against a market price of $6.94. That is a margin of safety of -11.0%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.